Feed Preview

Fast Growing

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Top 20 most recent papers

Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation

European Heart JournalNovember 23, 2019

Stephan WillemsPaulus Kirchhof

Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial

Circulation. Arrhythmia and ElectrophysiologyNovember 26, 2019

Karl-Heinz KuckGerhard Hindricks

Medical Therapies for Heart Failure With Preserved Ejection Fraction

HypertensionDecember 2, 2019

Sverre Erik KjeldsenFaïez Zannad

Rethinking drug design in the artificial intelligence era

Nature Reviews. Drug DiscoveryDecember 4, 2019

Petra SchneiderGisbert Schneider

116

Cryoablation for persistent and longstanding persistent atrial fibrillation: results from a multicentre European registry

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of CardiologyDecember 6, 2019

Vinit SawhneyRoss Jacob Hunter

Symptomatic arrhythmias after catheter ablation of atrioventricular nodal reentrant tachycardia (AVNRT): results from the German Ablation Registry

Clinical Research in Cardiology : Official Journal of the German Cardiac SocietyNovember 29, 2019

Maura M ZyllaDierk Thomas

Clopidogrel plus Aspirin Use is Associated with Worse Long-Term Outcomes, but Aspirin Use Alone is Safe in Patients with Vasospastic Angina: Results from the VA-Korea Registry, A Prospective Multi-Center Cohort

Scientific ReportsNovember 28, 2019

Seong Sik ChoSang Hong Baek

Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs

JAMA CardiologyNovember 27, 2019

Aylin Ornelas-LoredoDawood Darbar

The Effect of Ranolazine on Glycemic Control: a Narrative Review to Define the Target Population

Cardiovascular Drugs and TherapyDecember 4, 2019

Dusty LisiHua Ling

Is ablation to atrial fibrillation termination of persistent atrial fibrillation the end point?: A systematic review and meta-analysis

MedicineNovember 1, 2019

Fanghui LiRui Zeng

Immuno-oncology drug development goes global

Nature Reviews. Drug DiscoveryNovember 1, 2019

Jia Xin YuJun Tang

293

Psychological interventions for co-occurring depression and substance use disorders

The Cochrane Database of Systematic ReviewsNovember 26, 2019

Leanne HidesAmanda L Baker

Particulate air pollution exposure during pregnancy and postpartum depression symptoms in women in Mexico City

Environment InternationalNovember 21, 2019

Megan M NiedzwieckiRosalind J Wright

Sports practice predicts better functional capacity in children and adults with Fontan circulation

International Journal of CardiologyNovember 16, 2019

João RatoRui Anjos

The role of amiodarone in contemporary management of complex cardiac arrhythmias

Pharmacological Research : the Official Journal of the Italian Pharmacological SocietyNovember 19, 2019

Nebojsa M MujovicTatjana S Potpara

Study on forced degradation behaviour of dofetilide by LC-PDA and Q-TOF/MS/MS: Mechanistic explanations of hydrolytic, oxidative and photocatalytic rearrangement of degradation products

Journal of Pharmaceutical and Biomedical AnalysisNovember 14, 2019

Bhargavi ThalluriM V Narendra Kumar Talluri

Sudden cardiac death in patients with myocarditis: Evaluation, risk stratification, and management

American Heart JournalAugust 15, 2019

Fatima Ali-AhmedSana M Al-Khatib

Engaging patients in medicines regulation: a tale of two agencies

Nature Reviews. Drug DiscoveryNovember 1, 2019

Maria MavrisNathalie Bere

Ventricular Arrhythmias in Patients With Left Ventricular Assist Device (LVAD)

Current Treatment Options in Cardiovascular MedicineNovember 27, 2019

Azza M AhmedMalini Madhavan

Adenosine-induced atrial fibrillation arising from arrhythmogenic right atrial appendage

Journal of Cardiovascular ElectrophysiologyDecember 5, 2019

Takeshi IshiharaHiroyuki Okura

See more papers from this feed

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Contact Help Terms Privacy Cookies